Who
Gary Sender
Director
Company insider
Files Form 4 as: Director, iBio; Director, Apnimed; Director, Schrodinger; Director, Harmony Biosciences Holdings; Chief Financial Officer, Nabriva Therapeutics; Chief Financial Officer, Nabriva Therapeutics.
In numbers
- Trades disclosed
- 79
- Buys
- 3
- Sells
- 2
- Bought
- $51K
- Sold
- $1.9M
- Companies
- 6
- Companies where not an officer
- 4
- First trade
- 7 Feb 2017
- Last trade
- 14 Oct 2026
- Last filed
- 15 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Oct 2026filed 15 Oct 2026 | IBIO iBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —38,000 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code D | —51,890 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code A | —51,890 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code D | —44,477 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code D | —51,890 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code A | —51,890 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code D | —44,477 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,477 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code D | —44,477 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,477 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,477 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code D | —44,477 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,477 at $0.00 | filing |
| 30 Jul 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,477 at $0.00 | filing |
| 30 Jul 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,477 at $0.00 | filing |
| 22 Jun 2026filed 23 Jun 2026 | SDGR SchrodingerLife-science tools | SEC FORM 4 Code A | —8,141 at $0.00 | filing |
| 22 Jun 2026filed 23 Jun 2026 | SDGR Schrodingeroption or derivative · Life-science tools | SEC FORM 4 Code A | —13,313 at $0.00 | filing |
| 22 Jun 2026filed 23 Jun 2026 | SDGR Schrodingeroption or derivative · Life-science tools | SEC FORM 4 Code A | —13,313 at $0.00 | filing |
| 22 Jun 2026filed 23 Jun 2026 | SDGR SchrodingerLife-science tools | SEC FORM 4 Code A | —8,141 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —21,872 at $0.00 | filing |
News
Claritev (NYSE:CTEV) and Schrodinger (NASDAQ:SDGR) Financial SurveySDGR · dailypolitical.com · 19 Oct 2026Head to Head Comparison: Myriad Genetics (NASDAQ:MYGN) & iBio (NASDAQ:IBIO)IBIO · themarketsdaily.com · 19 Oct 2026Head to Head Review: Schrodinger (NASDAQ:SDGR) versus VSee Health (NASDAQ:VSEE)SDGR · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name Gary Sender; 3 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.